AiCuris GmbH & Co. KG
🏢 View company profile →54Patents
49Active
54Granted
51Portfolio score
Filing activity: Jun 10, 2002 → Jan 26, 2022 · 24 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9616105B2 | Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T cells | Chemistry; Metallurgy | 23 | Active |
| US10086046B2 | Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells | Chemistry; Metallurgy | 20 | Active |
| US8784887B2 | Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide | Chemistry; Metallurgy | 13 | Active |
| US9119786B2 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Emerging Cross-Sectional Technologies | 10 | Active |
| US7897159B2 | Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer | Chemistry; Metallurgy | 10 | Active |
| US8513255B2 | Substituted dihydroquinazolines | Human Necessities | 9 | Active |
| US8084604B2 | Process for the preparation of dihydroquinazolines | Chemistry; Metallurgy | 7 | Active |
| US9340535B2 | N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate | Human Necessities | 5 | Active |
| US8372972B2 | Process for the preparation of dihydroquinazolines | Chemistry; Metallurgy | 4 | Active |
| US7368424B2 | Acylated nonadepsipeptides | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7531507B2 | Acylated nonadepsipeptides containing pyridyl alanine residues | Human Necessities | 4 | Expired |
| US9512085B2 | Salts of a dihydroquinazoline derivative | Chemistry; Metallurgy | 4 | Active |
| US7883713B2 | Topical application of thiazolyl amides | Human Necessities | 4 | Expired |
| US8314113B2 | Substituted dihydroquinazolines II | Human Necessities | 4 | Active |
| US8816075B2 | Process for the preparation of dihydroquinazolines | Chemistry; Metallurgy | 3 | Active |
| US9637459B2 | Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents | Chemistry; Metallurgy | 3 | Active |
| US8357363B2 | Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom | Chemistry; Metallurgy | 3 | Expired |
| US8318761B2 | Substituted arylsulfonamides as antiviral agents | Chemistry; Metallurgy | 3 | Active |
| US8314089B2 | Substituted pyrazolamides and their use | Chemistry; Metallurgy | 3 | Active |
| US8399682B2 | Substituted (pyrazolylcarbonyl)imidazolidinones and their use | Chemistry; Metallurgy | 2 | Active |
| US7569563B2 | Substituted quinolones II | Human Necessities | 2 | Active |
| US8343981B2 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | Human Necessities | 2 | Active |
| US9458433B2 | Production of dense bodies (DB) from HCMV-infected cells | Chemistry; Metallurgy | 2 | Active |
| US8198282B2 | Substituted azaquinazolines having an antiviral action | Human Necessities | 2 | Active |
| US7919489B2 | Heterocyclyamide-substituted imidazoles | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.